Description
ICPA Nummit Topical Anesthetic Spray
is a specialized local anesthetic designed for effective pain relief in dental and medical procedures. Formulated with Lidocaine, this spray works by reversibly blocking nerve transmission in a targeted area, binding to sodium channels in the nerve membrane to prevent the entry of sodium ions during depolarization.
This mechanism ensures localized numbness, making it ideal for preoperative surface anesthesia and alleviating discomfort from painful oral conditions. The convenient spray application allows for precise delivery and rapid onset of action, enhancing patient comfort during procedures.
Whether used in dental practices or for minor medical interventions, ICPA Nummit provides reliable and effective pain management, helping to ease anxiety and improve the overall patient experience.
Features:
ICPA Nummit Topical Anesthetic is designed for easy administration, allowing dental and medical professionals to apply it quickly and accurately using the convenient spray format.
This anesthetic enables faster absorption into the tissues, leading to a quicker onset of action. Patients experience prompt relief from discomfort, making it ideal for immediate pain management.
ICPA Nummit provides an extended duration of anesthesia, ensuring that pain relief lasts throughout longer procedures, minimizing the need for repeated applications.
The spray is CFC-free, making it an environmentally friendly choice while still providing effective pain relief without compromising safety.
The spray format allows for targeted application, making it easy to administer in various clinical settings, enhancing both patient comfort and treatment efficiency.
Key specifications:
Category: Local Anesthetic agent
Type: Topical
Form: Spray
Usage: Preoperative surface anesthesia and for painful oral conditions
Composition: Lidocaine 15% w/w
Inert solvents & Propellant q.s. to 100% w/w
Flavor: Mint
Dosage: Each actuation delivers 7.5mg of Lidocaine USP
Pacakaging:
1 x 100gm
Reviews
There are no reviews yet.